Location: Home
  • search
  • go
  • Relate News
  • 6/13/2023NMPA Announces Package Insert Revision of Betahistine Preparations
  • 6/13/2023Responding to Challenges in the Chinese Healthcare Market Volume Based...
  • 6/12/2023China's Growth as Pharmaceutical Hub for APIs to Continue (BioSpectrum...
  • 6/12/2023China Wakes Up to Danger From Illegal Lab Monkey Trade (Sixth Tone)
  • 6/12/2023Understanding China's Rapidly Growing Healthcare Market (China Briefin...
  • 6/12/2023China's BMI Fund Income and Expenditure Up 8.1% and 23.1% in First Fo...
  • 6/12/2023China Announces 81 Pilot Regions for Integrated Medical Services
  • 6/9/2023Biomarin Reportedly Not to Renew Import Drug License of Orphan Drug Vi...
  • 6/9/2023NHC Solicits Comments on the Proposed Biosafety Standards for Vaccine ...
  • 6/9/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (71...
  • 6/9/2023CDE Issues the Technical Guidelines for Clinical Trial Design of New N...
  • 6/9/2023NHSA Releases the Draft Working Plan and the Application Guide for Adj...
  • 6/9/2023Recent Executive Moves
  • 6/9/2023Drug R&D and Product Registration News Digest June 2023 (2)
  • 6/9/2023May Was a Big Month for Oncology Therapies in China (PharmaDJ)
  • 6/8/2023How China's Detailed Human Genetic Resources Rules May Impact MNC Life...
  • 6/7/2023Chinese Drugmakers Seek to Emulate the Success of Novo Nordisk's Wegov...
  • 6/7/2023Fosun Pharma to Build African Drug Manufacturing Plant with Help from ...
  • 6/6/2023NH: China CHC Growth Slows in 2022 vs 2021
  • 6/5/2023Aurobindo Pharma Completes Plant Installation in China
  • 6/5/2023Ozempic Frenzy Hitting China as the Country Prepares to Approve It for...
  • 6/5/2023Chinese Pharma Performance A Mix Bag This Year as the Country Renews C...
  • 6/5/2023China Races into New-Generation Obesity Drug Arena with Potential Asse...
  • 6/5/2023AstraZeneca Defies Geopolitics to Bet on China (FT)
  • 6/5/2023British Businesses in China: Conditionally Optimistic for 2023 (China ...
  • 6/2/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (70...
  • 6/2/2023FDA Permits Temporary Import of Unapproved Chinese Cancer Drug to Alle...
  • 6/2/2023Drug R&D and Product Registration News Digest June 2023 (1)
  • 6/1/2023Impact Thera Entered into Global Partnership with Eikon Thera for PARP...
  • 6/1/2023China Issues the Implementing Rules for Regulations on the Management ...
  • Page:131/806 Total number of articles:24168: [First][<<] [129] [130] [131] [132] [133] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group